NCT06654089

A Study Evaluating Quality of Life Parameters Following Use of Emergen-C

A Real-World Evidence Study Evaluating Quality of Life Parameters Following Use of Emergen-C

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 299 (actual)
• Sponsor: HALEON · Industry
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine how Emergen-C use can improve quality of life (QoL) in a real-world setting to help consumers and healthcare professionals understand the benefits of taking Emergen-C on a routine or daily basis.

Detailed description

This will be a randomized, double-blinded, placebo-controlled clinical trial to evaluate the over-time effects of 12-weeks Emergen-C supplementation on QoL parameters in a real-world setting. This study will be entirely decentralized, and participants will not be required to physically attend any on-site visits. All study data will be collected remotely through a study platform using the participant's personal mobile device, tablet or computer. Sufficient participants will be screened to enroll approximately 300 eligible participants (approximately 150 participants per group) and approximately 240 participants are expected to complete the study (approximately 120 participants per group).

Conditions

• Dietary Supplements

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Emergen-C Core Super Orange Powder	A dietary supplement powder containing vitamin C, zinc, vitamin B6, vitamin B12, folate, and manganese.
DIETARY_SUPPLEMENT	Placebo	To ensure proper blinding, the placebo was formulated to be indistinguishable from Emergen-C in taste, appearance, and other sensory characteristics. The placebo therefore contained fructose, and the electrolytes potassium, magnesium, calcium, and sodium.

Timeline

• Start date: 2024-10-30
• Primary completion: 2025-02-24
• Completion: 2025-02-24
• First posted: 2024-10-23
• Last updated: 2026-04-07
• Results posted: 2026-03-10

Locations

1 site across 1 country: United States